Envoy Medical files second FDA module for Acclaim cochlear implant

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. META
6. TSLA
7. RTX
8. SMCI
9. S
10. COF

Go back to Envoy Medical files second FDA module for Acclaim cochlear implant

Envoy Medical Submits Second Module of Modular Premarket Approval Application to FDA for Breakthrough Designated Acclaim(R) Cochlear Implant

October 12, 2026 8:31 AM EDT

Second of Four Planned Modules Moves Rolling FDA Review Forward

Advances Toward Targeted Completion of the Final Clinical Module Submission in Q2 2027

White Bear Lake, Minnesota--(Newsfile Corp. - October 12, 2026) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health and neuroprosthetics company pioneering fully implanted hearing solutions, today announced the submission of the second module of its Modular Premarket Approval ("PMA") application to the U.S. Food and Drug Administration ("FDA") for the... More